Target Name: MIR1253
NCBI ID: G100302208
Review Report on MIR1253 Target / Biomarker Content of Review Report on MIR1253 Target / Biomarker
MIR1253
Other Name(s): microRNA 1253 | MIRN1253 | hsa-miR-1253 | MicroRNA 1253 | hsa-mir-1253

MIR1253: A Potential Drug Target and Biomarker for Obesity

Obesity has become a significant public health issue worldwide, with over 20% of adults falling in the category of being overweight or obese. The increasing prevalence of obesity has led to a range of health problems, including cardiovascular diseases, diabetes, and certain types of cancer. While there are several treatments available for obesity, there is a need for new and more effective approaches.

One potential drug target for obesity is MIR1253, a protein that is expressed in human tissues and has been shown to play a role in the development and progression of obesity. MIR1253 has also been identified as a potential biomarker for obesity, with studies suggesting that it may be a useful indicator of the severity of obesity.

The MIR1253 protein is a member of the Integrin alpha-2 (IAA) family, which is known for their role in cell-cell adhesion and migration. MIR1253 is expressed in various human tissues, including fat tissue, and has been shown to be involved in the development of obesity.

One of the key functions of MIR1253 is its role in the regulation of energy metabolism. Obesity is often associated with an imbalance in energy intake and energy expenditure, and MIR1253 has been shown to be involved in this process.

MIR1253 has been shown to promote the formation of lipid droplets in human fat tissue, which are thought to play a key role in the development of obesity. Additionally, MIR1253 has been shown to increase the expression of genes involved in energy metabolism, suggesting that it may be involved in the regulation of energy intake and output.

In addition to its role in energy metabolism, MIR1253 has also been shown to be involved in the regulation of inflammation. Obesity is often associated with an increase in inflammation in the body, and MIR1253 has been shown to be involved in reducing inflammation.

The MIR1253 gene has also been shown to be expressed in human fat tissue, suggesting that it may be a potential biomarker for obesity. Additionally, studies have suggested that MIR1253 may be involved in the regulation of cellular processes that are related to obesity, such as insulin sensitivity and inflammation.

While more research is needed, MIR1253 is an attractive potential drug target for obesity because it is involved in the regulation of energy metabolism, inflammation, and cellular processes that are related to obesity. Additionally, because MIR1253 is expressed in various human tissues, it may be a useful biomarker for tracking the effectiveness of potential treatments for obesity.

In conclusion, MIR1253 is a protein that has been shown to play a role in the development and progression of obesity. It is expressed in various human tissues and has been shown to be involved in the regulation of energy metabolism, inflammation, and cellular processes that are related to obesity. Further research is needed to fully understand the role of MIR1253 in obesity and to develop effective treatments.

Protein Name: MicroRNA 1253

The "MIR1253 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR1253 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR1254 | MIR1255A | MIR1255B1 | MIR1255B2 | MIR1256 | MIR1257 | MIR1258 | MIR125A | MIR125B1 | MIR125B2 | MIR126 | MIR1260A | MIR1260B | MIR1261 | MIR1262 | MIR1263 | MIR1264 | MIR1265 | MIR1266 | MIR1267 | MIR1268A | MIR1268B | MIR1269A | MIR1269B | MIR127 | MIR1270 | MIR1271 | MIR1272 | MIR1273A | MIR1273C | MIR1273H | MIR1275 | MIR1276 | MIR1277 | MIR1278 | MIR1279 | MIR128-1 | MIR128-2 | MIR1280 | MIR1281 | MIR1282 | MIR1283-1 | MIR1283-2 | MIR1284 | MIR1285-1 | MIR1285-2 | MIR1286 | MIR1287 | MIR1288 | MIR1289-1 | MIR1289-2 | MIR129-1 | MIR129-2 | MIR1290 | MIR1291 | MIR1292 | MIR1293 | MIR1294 | MIR1295A | MIR1295B | MIR1296 | MIR1297 | MIR1298 | MIR1299 | MIR1301 | MIR1302-1 | MIR1302-10 | MIR1302-11 | MIR1302-2 | MIR1302-3 | MIR1302-4 | MIR1302-5 | MIR1302-6 | MIR1302-7 | MIR1302-8 | MIR1302-9 | MIR1303 | MIR1304 | MIR1305 | MIR1306 | MIR1307 | MIR130A | MIR130B | MIR132 | MIR1321 | MIR1322 | MIR1323 | MIR1324 | MIR133A1 | MIR133A1HG | MIR133A2 | MIR133B | MIR134 | MIR1343 | MIR135A1 | MIR135A2 | MIR135B | MIR136 | MIR137 | MIR137HG